Clincosm LogoSign in Get a demo

Global Impact of COVID-19 on Pulmonology Special Units

Sponsor
Assiut University (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04554251
Collaborator
(none)
100
Enrollment
1
Location
3.9
Anticipated Duration (Months)
25.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The COVID-19 pandemic is having a profound impact on the world. As of May 18, 2020, there were 4,889,287 confirmed cases and 322,683 deaths globally. The healthcare system is wrestling with a virus that threatens to overwhelm hospital capacity, while simultaneously confronting an unprecedented reduction in elective and non-essential care.

A survey by the American Cancer Society showed that 50% of cancer patients and survivors reported some impact to their healthcare due to the COVID-19 epidemic.

A recent survey was conducted by Forbes et al to evaluate the changes in GI and endoscopy practices in North America.

However, the impact of this epidemic on Pulmonology units ( bronchoscopy, thoracoscopy, ultrsonography and sleep lab) globally has not been studied.

Condition or Disease Intervention/Treatment Phase
  • Other: Survey

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Global Impact of COVID-19 on Pulmonology Special Units (Bronchoscopy, Thoracoscopy, Ultrasonography and Sleep Lab)
Actual Study Start Date :
Sep 1, 2020
Anticipated Primary Completion Date :
Dec 1, 2020
Anticipated Study Completion Date :
Dec 30, 2020

Outcome Measures

Primary Outcome Measures

  1. global impact of COVID-19 on baseline patients number [6 months]

    number of patients and procedures before and after pandemic

  2. measure the changes in practice in each unit [6 months]

    use of PPE

  3. frequency of SARS-CoV-2 infection in healthcare workers [6 months]

    SARS-CoC-2 infection

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Working registered invited pulmonology units; governmental, university, private
Exclusion Criteria:
  • non pulmonary medicine registered units

Contacts and Locations

Locations

Site City State Country Postal Code
1 Aliae Mohamed-Hussein Assiut Egypt 71515

Sponsors and Collaborators

  • Assiut University

Investigators

  • Study Chair: Aliae Mohamed-Hussein, Assiut University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aliae AR Mohamed Hussein, Professor of Pulmonology, Assiut University
ClinicalTrials.gov Identifier:
NCT04554251
Other Study ID Numbers:
  • Assiut20
First Posted:
Sep 18, 2020
Last Update Posted:
Sep 18, 2020
Last Verified:
Sep 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Aliae AR Mohamed Hussein, Professor of Pulmonology, Assiut University
Bronchoscopy
Thoracoscopy
Thoracic ultrasonography
Sleep Lab
Global impact
Additional relevant MeSH terms:
COVID-19

Study Results

No Results Posted as of Sep 18, 2020